These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2695186)

  • 21. New approaches to adjuvant chemotherapy for breast cancer.
    Hudis C
    Pharmacotherapy; 1996; 16(3 Pt 2):88S-93S. PubMed ID: 8726587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gleaning from the American Oncology Congress. A new standard in colorectal carcinoma].
    MMW Fortschr Med; 2002 Oct; 144(41):61. PubMed ID: 12474374
    [No Abstract]   [Full Text] [Related]  

  • 23. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Norton-Simon hypothesis revisited.
    Norton L; Simon R
    Cancer Treat Rep; 1986 Jan; 70(1):163-9. PubMed ID: 3510732
    [No Abstract]   [Full Text] [Related]  

  • 25. A biological approach to breast cancer.
    Wall P
    Radiography; 1986; 52(603):125-30. PubMed ID: 3749491
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical and molecular complete remission in a case of variant hairy cell leukemia treated with DHAP followed by high-dose chemotherapy plus rituximab.
    Goldaniga M; Guffanti A; Gianelli U; Magni M; Lambertenghi Deliliers G; Baldini L
    Haematologica; 2004 Nov; 89(11):ECR41. PubMed ID: 15533846
    [No Abstract]   [Full Text] [Related]  

  • 27. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrasting effects of extended low dose versus standard dose shorter course UFT chemotherapy on microscopic versus macroscopic established tumors: implications for optimal postoperative adjuvant chemotherapy.
    Uchida J; Okabe H; Nakano K; Fujioka A; Saito H; Sugimoto Y; Oka T; Fukushima M
    Oncol Rep; 2007 Aug; 18(2):313-9. PubMed ID: 17611650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When less is more.
    Kaiser J
    Science; 2017 Mar; 355(6330):1144-1146. PubMed ID: 28302821
    [No Abstract]   [Full Text] [Related]  

  • 30. [Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer].
    Rühl U
    Strahlenther Onkol; 2000 Apr; 176(4):196-7. PubMed ID: 10812394
    [No Abstract]   [Full Text] [Related]  

  • 31. Cancer chemotherapy.
    Med Lett Drugs Ther; 1985 Feb; 27(681):13-20. PubMed ID: 3974519
    [No Abstract]   [Full Text] [Related]  

  • 32. The influence of microenvironmental factors during cancer therapy.
    Durand RE
    In Vivo; 1994; 8(5):691-702. PubMed ID: 7727714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relation dose efficacy in chemotherapy: the example of breast cancer].
    Chevallier B; Perrocheau G
    Bull Cancer; 1995; 82 Suppl 1():9s-15s. PubMed ID: 7626858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calculating dose intensity.
    Coldman AJ; Coppin CM
    J Clin Oncol; 1991 Sep; 9(9):1713-4. PubMed ID: 1875226
    [No Abstract]   [Full Text] [Related]  

  • 35. Dose-response relationship in experimental and clinical oncology.
    Brade WP; Freireich EJ; Goldin A
    Cancer Treat Rev; 1984 Dec; 11(4):279-83. PubMed ID: 6398757
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemotherapy.
    Pinedo HM; Giaccone G
    Lancet; 1997 May; 349 Suppl 2():SII7-9. PubMed ID: 9164439
    [No Abstract]   [Full Text] [Related]  

  • 37. The dose-dense principle in chemotherapy.
    López ÁG; Iarosz KC; Batista AM; Seoane JM; Viana RL; Sanjuán MAF
    J Theor Biol; 2017 Oct; 430():169-176. PubMed ID: 28689890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cancerogenic activity of antineoplastic chemotherapeutics].
    Cardinali G; Scoponi C; Trivisonne R
    Recenti Prog Med; 1977 Dec; 63(6):649-68. PubMed ID: 580473
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluating and designing cancer chemotherapy treatment using mathematical models.
    Birkhead BG; Gregory WM; Slevin ML; Harvey VJ
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):3-8. PubMed ID: 3956557
    [No Abstract]   [Full Text] [Related]  

  • 40. Modelling the effect of chemotherapy intensity.
    Coppin C; Coldman A; Goldie J
    Prog Clin Biol Res; 1990; 354B():103-16. PubMed ID: 2236160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.